562 Benefit from Atezolizumab in Patients with a Poor Prognostic Ovarian Cancer in First-Line Setting: IMAGYN-050 Trial
Benoit You,Charles Anderson,Sabrina Chiara Cecere,Aurore Carrot,Tashanna Myers,Florian Heitz,Sharma Sudarshan,Fatih Selçukbiricik,Carol Aghajanian,Josefin Fernebro,Stephanie Blank,Maria Elena Laudani,Premal Thaker,Mayu Yunokawa, Lynday willmott, Yvette He,Charles Landen,Yvonne G Lin,Jesús alarcón,Kathleen N Moore Oral Sessions（2024）
AI 理解论文
溯源树
样例
